Bruce Pollock

Research Synopsis

Dr. Pollock is internationally recognized for his work in geriatric clinical psychopharmacology. His overarching research objective is improved therapeutic approaches to geriatric care and his work includes clinical studies examining neurochemical selectivity, pharmacokinetics, and neurophysiological-therapeutic effects of conventional or newly derived/modified agents for the treatment of depression and the behavioural disturbances of dementia. Dr. Pollock is listed by ISI as among the 1% most cited authors in the field of geriatric psychiatry.

As the inaugural Peter and Shelagh Godsoe Chair in Late-Life Mental Health, Dr. Pollock will focus on developing collaboration in the field of late-life mental health within Toronto and between the Toronto research community and abroad. He will also devote his mentoring skills to support early career scientists and their transition to more established roles.

He has had a leadership role in numerous clinical trials, and the U.S. National Institutes of Health has continuously funded his research on psychiatric disorders in geriatric patients since 1990.